Aurinia Pharmaceuticals Inc. — Director's Dealing 2022

May 20, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aurinia Pharmaceuticals Inc. (AUPH)
CIK: 0001600620
Period of Report: 2022-05-18

Reporting Person: Balakrishnan Brinda (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-18	Restricted Stock Unit	$	A	8733	Acquired		Common Shares (8733.0)	Direct
2022-05-18	Stock Option (right to buy)	$11.45	A	14612	Acquired	2032-05-18	Common Stock (14612.0)	Direct

Footnotes

F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuers common stock. The RSUs will vest and be delivered to the Reporting Person one year from date of grant.

F2: The option vests in twelve equal monthly installments commencing on June 18, 2022.